Conversely, several studies have shown that excessive RhoA activation is also detrimental in diabetic nephropathy and that its inhibition may offer therapeutic benefits (Kolavennu et al., 2008; Komers, 2013). The gene discussed is RHOA; the disease is diabetic kidney disease.